Clinical Trial Update: Transplantation of Allogeneic MSC in Patients With Pulp Necrosis and Chronic Apical Periodontitis [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating allogeneic mesenchymal stromal cell transplantation for pulp necrosis and chronic apical periodontitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Apical Periodontitis
• Pulp Necrosis

Snippet

Sponsor: Universidad Central de Venezuela | Conditions: Pulp Necroses, Apical Periodontitis | Phase 2, Phase 3 | Status: COMPLETED